Inventor

SORRENTINO JESSICA A

US8 patents

⚠️ This page may combine multiple inventors who share the name “SORRENTINO JESSICA A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

G1 THERAPEUTICS INC

7 patents

US11090306B2Aug 17, 2021

Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors

G1 THERAPEUTICS INC9 citations84

US11395821B2Jul 26, 2022

Treatment of EGFR-driven cancer with fewer side effects

G1 THERAPEUTICS INC9 citations83

US10413547B2Sep 17, 2019

Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors

G1 THERAPEUTICS INC11 citations83

US11529352B2Dec 20, 2022

Preservation of immune response during chemotherapy regimens

G1 THERAPEUTICS INC6 citations82

US10231969B2Mar 19, 2019

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors

G1 THERAPEUTICS INC12 citations82

US12285431B2Apr 29, 2025

Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors

G1 THERAPEUTICS INC2 citations73

US11446295B2Sep 20, 2022

Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors

G1 THERAPEUTICS INC4 citations71

PHARMACOSMOS HOLDING AS

1 patent

US12527798B2Jan 20, 2026

Preservation of immune response during chemotherapy regimens

PHARMACOSMOS HOLDING AS0 citations59